Natural Cycles gets $30M for its EU-certified “digital contraception”

Contraception can be a charged topic for many reasons. It’s highly personal, of course. Frequently it’s political. And the stakes, should your method of choice fail, are obviously very high indeed.

Which perhaps explains why there hasn’t been a whole lot of innovation in the space — unless you count the prospect of a male pill which nonetheless still hasn’t arrived on the market.

None of these challenges have deterred European startup Natural Cycles from pushing to establish what it bills as a “digital contraceptive” into the market as another method for couples to consider — assuming they’re comfortable having unprotected sex (which of course means no protection against the risk of STDs).

Last July the team announced a $6M Series A round. Today they’re…

Read Story